Showing results (1-10 of 312) with videos related to
Sort By:
Pageof 32
Anticancer Research|May 16, 2000
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinomaJ T Hartmann, L Kanz, C BokemeyerDrugs|September 3, 1999
Diagnosis and treatment of patients with testicular germ cell cancerJ T Hartmann, L Kanz, C BokemeyerEuropean Journal of Clinical Investigation|November 12, 2005
Anaemia in cancer patients: pathophysiology, incidence and treatmentC Bokemeyer, K Oechsle, J-T HartmannPraxis|December 31, 1997
[Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma]C Bokemeyer, J T Hartmann, L KanzInternational Journal of Cancer|December 22, 1999
Platinum organ toxicity and possible prevention in patients with testicular cancerJ T Hartmann, C Kollmannsberger, L Kanz, et al.International Journal of Cancer|December 22, 1999
Therapy-related malignancies following treatment of germ cell cancerC Kollmannsberger, J T Hartmann, L Kanz, et al.Journal of Cancer Research and Clinical Oncology|June 10, 1998
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignanciesC Kollmannsberger, J T Hartmann, L Kanz, et al.European Journal of Cancer (Oxford, England : 1990)|December 7, 2007
Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapyC Sammler, J Beyer, C Bokemeyer, et al.Oncology (Williston Park, N.Y.)|August 12, 1999
UFT/calcium folinate plus weekly paclitaxel for solid tumorsC Bokemeyer, J T Hartmann, C Kollmannsberger, et al.Pageof 32